Two very different origins
Hydroxyzine came out of antihistamine research in the 1950s. Gabapentin was developed as an anticonvulsant, and its approved labeling covers seizure and nerve pain indications depending on the specific product.
They meet in practice because both end up being used in contexts their labeling does not fully describe. Hydroxyzine is used off-label for sleep; gabapentin is used off-label for anxiety and sleep in various settings.
Off-label use is legal, common, and often grounded in clinical experience. It also means that for those uses, the labeling provides no dosing framework, no guidance on duration, and no approved way to assess whether it is working — which puts more weight on the conversation with the prescriber.
The respiratory depression warning
This is the most safety-relevant item on the page.
Gabapentin labeling includes warnings about the risk of serious breathing difficulties when it is used together with opioids or other medicines that depress the central nervous system, and notes that people with reduced respiratory function or with certain lung conditions may be at higher risk.
Respiratory depression means breathing that becomes too slow or too shallow to maintain normal oxygen levels. Anyone taking gabapentin alongside an opioid, a benzodiazepine, or another sedating medicine should have that combination explicitly reviewed rather than assumed to be fine.
Warning signs that require emergency services: slow, shallow or irregular breathing; blue-tinged lips or fingertips; someone who cannot be roused.
Stopping, and the kidney question
Discontinuation
Gabapentin labeling advises against abrupt discontinuation. Stopping should be done under a prescriber's direction, typically gradually. This is a practical difference worth knowing before starting, not after.
Kidney function
Gabapentin is substantially dependent on the kidneys for elimination, and dose considerations relate closely to kidney function. Anyone with reduced kidney function, and anyone whose kidney function changes, needs that reflected in their prescription — which is one reason blood tests may be part of monitoring.
State scheduling
Gabapentin is not federally scheduled, but several states have placed it under state-level control, which affects how it is prescribed and dispensed locally. A pharmacist can confirm the position in your state.
Why gabapentin enters anxiety and sleep conversations
Gabapentin was developed and approved for neurological indications — seizures and certain nerve pain patterns depending on the product. It is not an antihistamine and does not act on histamine receptors.
It appears in anxiety and sleep discussions because clinicians sometimes prescribe it off-label when other approaches are unsuitable or insufficient. Off-label use is legal and common, but it means the official labeling contains no approved framework for that purpose: no described dosing for anxiety, no duration guidance for sleep use, no approved way to judge success.
Hydroxyzine, by contrast, has labeled uses that include symptomatic relief of anxiety and tension. Sleep use of hydroxyzine is typically off-label, but the anxiety indication is on-label — a meaningful regulatory distinction even though neither situation provides a website enough information to recommend one over the other.
The practical takeaway is that gabapentin prescriptions for mood or sleep symptoms deserve an explicit conversation about goals, timeframe, and how you will both know whether to continue.
State scheduling and what it changes locally
Gabapentin is not a federally controlled substance in the United States, but several states have placed it under state-level control because of concerns about misuse in combination with other depressants. That affects how it is prescribed, dispensed and refilled in those states — details a local pharmacist can explain better than any national reference.
Hydroxyzine is not federally scheduled and is not commonly subject to the same state-level controls as gabapentin in most jurisdictions. Not being scheduled does not mean either medicine is risk-free; it means the regulatory framework around prescribing and refills differs.
If you receive gabapentin and notice stricter refill rules than you expected, ask the pharmacist whether state law is the reason. Understanding the framework reduces frustration and prevents gaps in treatment when a refill is delayed.